The purpose of this study was to determine the changes in interstitial fluid (ISF) adenosine and cere bral blood flow (CBF) during inhibition of adenosine ki nase or adenosine deaminase. Brain microdialysis was used to (a) measure CBF (H2 clearance), (b) sample ce rebral ISF, and (c) deliver drugs locally to the brain. Mi crodialysis probes were implanted bilaterally in the caudate nucleus of halothane-anesthetized rats (n = 11). One probe was perfused with artificial cerebrospinal fluid (CSF) containing iodotubercidin (IODO), an adenosine kinase inhibitor, while the other probe was perfused with erythro-2-(2-hydroxy-3-nonyl)adenine (EHNA), an aden osine deaminase inhibitor. Both probes were subse quently perfused with EHNA + IODO. Finally, 8-(p sulfophenyl)theophylline (SPT), an adenosine receptor Adenosine, a purine nucleoside, has been pro posed to be a regulator of cerebral blood flow (CBF) and a modulator of synaptic activity (Dunwiddie, 1985; Van Wylen et aI., 1991). Because these ac tions are mediated by the interaction of adenosine with extracellular-oriented, membrane-bound re ceptors, changes in extracellular adenosine levels are important to CNS function. Two enzymes in volved in the control of brain adenosine levels are adenosine kinase, which phosphorylates adenosine to form 5'-AMP, and adenosine deaminase, which deaminates adenosine to form inosine. Adenosine 201 antagonist, was added to EHNA + IODO in one probe, while the other probe continued to receive only EHNA + IODO. CBF and dialysate adenosine levels increased with either EHNA or IODO; however, the increases were greater with IODO. EHNA + IODO further increased CBF and dialysate adenosine. The hyperemia observed with EHNA + IODO was abolished by adenosine recep tor blockade. These data suggest that basal adenosine levels are influenced to a greater extent by adenosine kinase than by adenosine deaminase. In addition, the in creased CBF observed with inhibition of adenosine me tabolism and the attenuation of this vasodilatory response with adenosine receptor blockade support a role for aden osine in CBF regulation.
Summary:
The purpose of this study was to determine the changes in interstitial fluid (ISF) adenosine and cere bral blood flow (CBF) during inhibition of adenosine ki nase or adenosine deaminase. Brain microdialysis was used to (a) measure CBF (H2 clearance), (b) sample ce rebral ISF, and (c) deliver drugs locally to the brain. Mi crodialysis probes were implanted bilaterally in the caudate nucleus of halothane-anesthetized rats (n = 11). One probe was perfused with artificial cerebrospinal fluid (CSF) containing iodotubercidin (IODO), an adenosine kinase inhibitor, while the other probe was perfused with erythro-2-(2-hydroxy-3-nonyl)adenine (EHNA), an aden osine deaminase inhibitor. Both probes were subse quently perfused with EHNA + IODO. Finally, 8-(p sulfophenyl)theophylline (SPT), an adenosine receptor Adenosine, a purine nucleoside, has been pro posed to be a regulator of cerebral blood flow (CBF) and a modulator of synaptic activity (Dunwiddie, 1985; Van Wylen et aI., 1991) . Because these ac tions are mediated by the interaction of adenosine with extracellular-oriented, membrane-bound re ceptors, changes in extracellular adenosine levels are important to CNS function. Two enzymes in volved in the control of brain adenosine levels are adenosine kinase, which phosphorylates adenosine to form 5'-AMP, and adenosine deaminase, which deaminates adenosine to form inosine. Adenosine antagonist, was added to EHNA + IODO in one probe, while the other probe continued to receive only EHNA + IODO. CBF and dialysate adenosine levels increased with either EHNA or IODO; however, the increases were greater with IODO. EHNA + IODO further increased CBF and dialysate adenosine. The hyperemia observed with EHNA + IODO was abolished by adenosine recep tor blockade. These data suggest that basal adenosine levels are influenced to a greater extent by adenosine kinase than by adenosine deaminase. In addition, the in creased CBF observed with inhibition of adenosine me tabolism and the attenuation of this vasodilatory response with adenosine receptor blockade support a role for aden osine in CBF regulation. Key Words: Inosine-Hypoxan thine-Microdialysis.
kinase has a lower Km (2 j.LM) than adenosine de aminase (17 j.LM) and approaches saturation under basal conditions (Phillips and Newsholme, 1979; Schrader, 1983; Mistry and Drummond, 1986) . Adenosine deaminase, which is widely dispersed throughout cells in the CNS, has a relatively high V max and plays a key role in adenosine metabolism (Manfredi and Holmes, 1985) . It has been proposed that adenosine levels are regulated in large part by the activity of these two enzymes (Arch and Newsholme, 1978; Newby and Holmquist, 1981; Schrader, 1983) .
The purpose of this study was to determine if inhibition of adenosine kinase and/or adenosine de aminase would result in increases in cerebral inter stitial fluid (ISF) levels of endogenous adenosine and be accompanied by increases in CBF. Addition ally, we determined if the responses elicited by in hibitors of adenosine metabolism could be attenu ated by adenosine receptor blockade. A modified brain microdialysis technique was used to (a) assess changes in ISF adenosine and adenosine metabo lites, (b) measure local CBF, and (c) deliver drugs locally to the brain.
METHODS

Animal preparation
All experiments were perlormed on 300--500 g adult male Wistar rats. Animals were anesthetized initially with sodium thiamylal (50 mg/kg-I), after which a trache ostomy was perlormed and the animals mechanically ven tilated with a mixture of oxygen, nitrogen, and 1.5-2.0% halothane. The core body temperature was monitored with a rectal temperature probe and maintained with a heating pad between 37 and 38°C. The left femoral artery was cannulated for the measurement of arterial blood pressure (Statham model P23Db pressure transducer, Gould 2400 recorder, Greenbelt, MD, U.S.A.) and the withdrawal of arterial blood samples.
In all animals, brain dialysate samples were collected bilaterally from the caudate nuclei. The details of the brain microdialysis technique as utilized by our labora tory have been published previously (Van Wylen et aI., 1986 , 1989 . In preparation for implantation of the microdialysis probes in the brain, the animals were placed in a stereotaxic apparatus and the frontal and parietal bones of the skull exposed. Bur holes were then made bilaterally 0.5 mm anterior and 2.5 mm lateral to the bregma and each of the microdialysis probes (Clirans TH 10, Terumo Corp., Tokyo, Japan; inner diameter of 300 f,Lm, molecular weight cutoff of 5,000 Da) was lowered 8 mm below the dura such that a 5-mm length of dialysis fiber between the ends of the two silica tubes rested pri marily in the caudate nucleus (Pelligrino et aI., 1979) . Once implanted in the brain, microdialysis probes were perlused with artificial cerebrospinal fluid (CSF) (NaC!, 132.8 mM; NaHC0 3 , 24.6 mM; urea, 6.7 mM; glucose, 3.7 mM; KCI, 3.0 mM; CaCI2, 2.0 mM; and MgCI2, 0.7 mM) at a constant flow of 0.5 f,LlImin (Carnegie Medicin AB model CMA100 microinjection pump, Lafayette, IN, U.S.A.).
CBF measurements
Local CBF was measured from the area surrounding the microdialysis probe by hydrogen clearance (Young, 1980) , using techniques previously described for local blood flow measurement in conjunction with brain mi crodialysis (Van Wylen et aI., 1988 , 1989 . Hydrogen was introduced to the animal in the inspired air (7-10%) for approximately 2 min, after which the inspired hydrogen was turned off and the washout of hydrogen from the tissue monitored. Local CBF was calculated from the time required for the hydrogen levels to fall from 90% maximum to 40% maximum using the following formula:
-In(40/90) CBF (ml min-1 100 g-l) = .
x 100 hme
Protocol
The protocols followed are shown in Table 1 . For all protocols, a 90-min period was allowed for recovery from microdialysis probe implantation, a time at which ISF purine levels have been shown to reach steady-state lev els (Van Wylen et aI., 1986) .
The first series of experiments (series 1) were per formed to determine a dose response to either erythro-2-(2-hydroxy-3-nonyl)adenine (EHNA, generously pro vided as a gift from Burroughs Wellcome Co., Research Triangle Park, NC, U.S.A.), an adenosine deaminase in hibitor, or iodotubercidin (Research Biochemicals Inc., Natick, MA, U.S.A.), an inhibitor of adenosine kinase. For each drug, four animals were used to determine a dose response. Following a baseline measurement of CBF and a 20-min collection of dialysate with both probes being perlused with CSF, the microdialysis probe on one side of the brain was perlused with CSF containing in creasing concentrations of either EHNA or iodotuberci din. Each solution was allowed to perluse the probe for � 10 min, after which time a 20 min dialysate sample was collected and a blood flow measurement was made. The concentration of the drug that consistently yielded both an increase in dialysate adenosine and an increase in CBF was the concentration that was used in series 2 experi ments. These concentrations were determined to be 10 -3 M EHNA and 10-5 M iodotubercidin. The second series of experiments (series 2, n = 11) was performed to investigate the effects of local infusion of both 10-3 MEHNA and 10-5 Miodotubercidin delivered alone, together, or in combination with 10-3 M 8-(sul fophenyl)theophylline (SPT; Research Biochemicals Inc., Natick, MA, U.S.A.), an adenosine receptor antagonist. This dose of SPT was used because it has been shown to attenuate the CBF response to local infusion of 5'-N ethylcarboximide adenosine (NECA), an adenosine re ceptor agonist (Van Wylen et aI., 1989) . As in the series 1 experiments, each solution was allowed to perfuse the probe for 10 min before dialysate collections were ini tiated and blood flow measurements made. Although two collections were made for each change in perfusate, data from only one time period are shown.
Analytical procedures
Determination of dialysate adenosine, inosine, and hy poxanthine concentrations was performed with reverse phase high-performance liquid chromatography (HPLC) (Waters, Division of Millipore, Milford, MA, U.S.A.) and ultraviolet detection at a wavelength of 254 nm (Waters Model 486 detector). Separation of the compounds of in terest was achieved using a CI8 column (Supelco Inc., Bellefonte, PA, U.S.A.) and a 1% (pH 5.3) to 25% (pH 5.58) methanol in 100 mM KH2P04 gradient. Identifica tion of nucleosides was accomplished by comparing re tention times and peak areas with those of external stan dards.
Statistical analysis
Mean values and standard deviations were calculated for all of the data. Differences between mean values were determined using one of two types of statistical analyses: (a) a paired t test with a Bonferroni correction was used to make multiple comparisons to baseline values within the same animal;, and (b) a paired t test was used for side to-side comparisons at the same time point. A p < 0.05 was accepted as indication of a statistically significant difference.
RESULTS
Local infusion of EHNA, iodotubercidin, or SPT did not affect arterial blood pressure, Po2, Pco2, pH, or heart rate. Arterial P02 (142 ± 14 mm Hg), Pco2 (39 ± 11 mm Hg), pH 7.4 ± 1.1), heart rate (333 ± 44 beats/min), and arterial blood pressure (95 ± 7 mm Hg) remained stable throughout the dura tion of the protocol (data are average baseline val ues for all animals in series 1 and series 2).
CBF and dialysate metabolite responses for se ries 1 experiments are presented in Tables 2 and 3 . On the untreated side of the brain, dialysate aden osine, inosine, and hypoxanthine did not change significantly throughout the protocol (data not shown). There was a dose-dependent increase in dialysate adenosine levels with infusion of either iodotubercidin or EHNA. CBF and dialysate aden osine levels were increased to a greater extent with iodotubercidin infusion than with EHNA infusion. The highest concentration of EHNA (10-3 M) also significantly decreased dialysate levels of inosine. There was a trend toward increased inosine levels with increasing concentrations of iodotubercidin. This increase in dialysate inosine was significant at the highest concentration of iodotubercidin tested (10-5 M).
The dialysate. metabolite results of series 2 exper iments are presented in Figs. 1-3 . The addition of 10 -3 M EHN A or 10 -5 M iodotubercidin to the dialysis probe resulted in 2-fold and 2.5-fold eleva tions of dialysate adenosine levels, respectively (Fig. 1) . When both drugs were perfused simulta neously through one probe, dialysate adenosine lev els were further elevated when compared to levels obtained with either drug alone. Dialysate adeno sine levels measured from probes perfused with the drug combination were elevated 350-400% when compared to baseline. Finally, when SPT was added to the drug combination perfusing one side of the brain, dialysate adenosine levels were signifi cantly increased when compared to levels obtained with the EHNAIiodotubercidin drug combination (2.92 ± 1.08 vs. 1.77 ± 0.55 fJ-M).
Dialysate inosine and hypoxanthine levels in re sponse to a local infusion of EHNAIiodotubercidini SPT are shown in Figs. 2 and 3 , respectively. Ino sine and hypoxanthine levels were significantly at- 62.65 ± 24.00 60.9 ± 22.0 69.0 ± 29.0 78.9 ± 32.0a.b
Cerebral blood flow (CBF) levels and dialysate adenosine, inosine, and hypoxanthine concentrations in response to increasing concentrations of erythro-(2-hydroxy-3-nonyl)adenine (EHNA). All values are mean ± SD obtained during perfusion with artificial CSF alone (baseline) or in combination with EHNA. a p < 0.05 compared to baseline (n = 4); bp < 0.05 compared to corresponding control side value. Cerebral blood flow (CBF) levels and dialysate adenosine, inosine, and hypoxanthine concentrations in response to increasing concentrations of iodotubercidin (1000). All values are mean ± SO obtained during perfusion with artificial CSF alone (baseline) or in compination with 1000 (n = 4). a p < 0.05 compared to baseline; bp < 0.05 compared to corresponding control side value. tenuated during local infusion of EHNA when compared to CSF infusion. When EHN A and iodo tubercidin were infused simultaneously, dialysate inosine and hypoxanthine levels were significantly lower than baseline.
CBF responses to local infusion of drugs are de picted in Fig. 4 . Local CBF was significantly in creased compared to baseline in the presence of EHNA (79 ± 25 vs. 66 ± 22 ml min -I 100 g-I ) or iodotubercidin (119 ± 52 vs. 61 ± 26 ml min -I 100 g-I ). CBF was significantly greater with iodotuber cidin compared to CBF with EHNA. Finally, SPT blocked the increase in CBF induced by EHNA + iodotubercidin, reducing the CBF to a level not dif ferent from baseline values.
DISCUSSION
Several enzymes can potentially contribute to the metabolism of adenosine in the brain. The purpose of this study was to investigate the effects of inhi bition of two such enzymes, adenosine kinase and adenosine deaminase, on brain ISF adenosine and adenosine metabolites and on CBF. The major find ings of this study were that (a) local delivery of EHNA, an adenosine deaminase inhibitor, or iodo tubercidin, an adenosine kinase inhibitor, resulted in significant increases in dialysate adenosine levels and regional CBF; (b) the increases in dialysate adenosine and CBF were augmented when both drugs were delivered simultaneously; and (c) the ... combined EHNA-and iodotubercidin-induced in crease in local CBF could be blocked by simulta neous infusion of the adenosine receptor antagonist SPT. At a perfusion rate of 0.5 f.LI min -I , complete equilibration does not occur between the artificial CSF and the surrounding ISF during flow through the dialysis fiber; therefore, dialysate levels of me tabolites are not equivalent to the ISF concentra tion of metabolites. In vitro percent recoveries of adenosine, inosine, and hypoxanthine from a mi crodialysis probe with a 5-mm dialysis fiber at a flow rate of 0.5 f.Ll/min are 48, 50, and 68%, respec tively (Van Wylen et aI., 1986) . Although these re coveries can be used to obtain estimates of ISF con centrations, we chose not to extrapolate from dial ysate concentrations to ISF concentrations, as m vivo and in vitro diffusion characteristics may dif fer. Instead, we prefer to present the actual dialy sate values with the belief that changes in dialysate concentrations are indicative of changes occurring in the ISF.
Adenosine deaminase, which catalyzes the deam ination of adenosine, has been localized to brain capillary endothelial cells (Schrader et aI., 1987) and neurons (Nagy et aI., 1985) by immunohisto chemical and radioligand techniques. Our data, which demonstrate an increase in dialysate adeno sine and a decrease in dialysate inosine with local EHNA infusion, are in agreement with Zetterstrom # * FIG. 1. Mean ± SD dialysate adenosine from both sides of the brain before local drug infusion (CSF), with perfusion of either EHNA or iodotubercidin (EHNAJIODO), with the drugs perfused in combination (E + I), and with one side of the brain perfused with SPT added to E + I (E + I + SPT). 'p < 0.05 compared to baseline; # p < 0.05 compared to opposite side (n = 11). (1982) . who reported similar changes in dial ysate adenosine and inosine in response to systemic administration of EHNA. In addition, Zetterstrom et ai. (1982) reported that the hypoxia-induced in crease in dialysate adenosine was augmented in EHNA-treated rats when compared to vehicle treated hypoxic animals. U sing the cortical cup technique, Phillis et ai. (1991) have recently shown that systemic administration of deoxycoformycin, a drug that also inhibits adenosine deaminase, slightly increased basal ISF adenosine and reduced inosine. They also reported an enhanced ischemia-evoked release of adenosine with deoxycoformycin. Bal larin et ai. (1991) have recently demonstrated a 1.4fold increase in dialysate adenosine and a decrease in dialysate inosine in conscious rats in response to local infusion of 10 -4 M deoxycoformycin. Finally, increases in dialysate adenosine and corresponding decreases in dialysate inosine with local infusion of EHNA have been reported by our laboratory in dog myocardium under basal conditions and during ischemia (Van Wylen and Delyani, 1991) . The purification and enzyme properties of rat brain adenosine kinase have been described (Phil lips and Newsholme, 1979; Yamada et aI., 1980) . We present here the first in vivo evidence of in creases in ISF adenosine, as measured by microdi alysis, as a result of adenosine kinase inhibition. The increase in dialysate adenosine we observed with iodotubercidin was significantly greater than the increase in dialysate adenosine with EHNA.
Our results are consistent with the known relative enzyme activities and binding affinities of adeno sine kinase and adenosine deaminase (Phillips and Newsholme, 1979; Mistry and Drummond, 1986) . Adenosine kinase, with a substrate affinity for adenosine that is 8-to 10-fold greater than that of adenosine deaminase, is believed to play a key role in the maintenance of the basal rate of adenosine formation. Thus, it is expected that inhibition of adenosine kinase would be more effective than in hibition of adenosine deaminase in altering basal concentrations of adenosine in the brain. While the primary actions of EHNA and iodotu bercidin most likely involve the inhibition of aden osine deaminase and adenosine kinase, respec tively, one cannot exclude the possibility that these two drugs, at the concentrations used in the perfus ate, may be acting via multiple mechanisms to in crease dialysate concentrations of adenosine. For example, in addition to its ability to inhibit adeno sine kinase, iodotubercidin has also been shown to inhibit cellular uptake of adenosine (Davies and Hambley, 1983) .
The increases in CBF correlate with increases in dialysate adenosine observed with infusion of EHNA, iodotubercidin, and the combination. Our data demonstrate that inhibition of adenosine ki nase was more effective in increasing the resting CBF than was adenosine deaminase inhibition.
There are no reports in the literature of the effects of iodotubercidin on brain blood flow. However, Phillis et ai. (1985) have reported that systemic EHNA fails to increase the resting CBF signifi cantly in the rat, as measured by a venous outflow technique. They did not, however, determine ISF concentrations of adenosine with EHN A treatment. The failure to achieve CSF concentrations of EHNA sufficient to elevate ISF adenosine levels may explain the discrepancy in their findings. We attribute the observed increase in CBF with enzyme inhibition to an increase in ISF adenosine. Our results are consistent with the known vasodila tory properties of adenosine as demonstrated when adenosine or adenosine analogues are delivered lo cally via microdialysis (Van Wylen et ai., 1989) or applied to isolated cerebral vessels (McBean et ai., 1988) , or to pial vessels (Wahl and Kuschinsky, 1976; Morii et ai., 1986) .
Methylxanthines such as SPT, theophylline, am inophylline, and caffeine are competitive blockers of adenosine receptors at micromolar concentra tions (Fredholm, 1980; RaIl, 1981) . Decreases in resting CBF or pial vessel diameter have been ob served following the administration of these adeno sine receptor antagonists (Grome and Stefanovich, 1986; Morii et ai., 1987; Pinard et ai., 1990) . In ad dition, the vasodilatory effect of local NECA, an adenosine agonist, has been shown to be inhibited by local SPT infusion (Van Wylen et ai., 1989) . The results of the present study, demonstrating a block ade of an enzyme inhibitor-induced increase in CBF with SPT, provide further evidence that the vascu lar response to adenosine is receptor mediated.
There are two potential interpretations of the aug mentation in dialysate adenosine caused by SPT in fusion. First, the local decrease in CBF in response J Cereb Blood Flow Metab, Vol. 13, No. 2, 1993 * FIG. 4. Mean + SD cerebral blood flow (CBF) from both sides of the brain before lo cal drug infusion (CSF), with perfusion of ei ther EHNA or iodotubercidin (EHNAIIODO), with the drugs perfused in combination (E + I), and with one side of the brain perfused with SPT added to E + I (E + I + SPT) .• p < 0.05 compared to baseline; # p < 0.05 com pared to opposite side (n = 11).
E+I E+I+SPT
to adenosine receptor blockade may be decreasing the amount of adenosine washed out of the ISF. Second, in addition to A2 receptor mediation of va sodilation, adenosine is also involved in inhibiting excitatory neurotransmission via an AI receptor mediated mechanism (Dunwiddie, 1985) . There fore, SPT, which blocks both adenosine A I and A2 receptors, may increase neuronal activity, reSUlting in an increase in adenosine production.
In summary, this study demonstrates that changes in local CBF and extracellular adenosine can be achieved by pharmacological inhibition of either adenosine deaminase or adenosine kinase. Furthermore, combined inhibition of both enzymes produces a further enhancement of CBF and ISF adenosine. Adenosine receptor blockade abolishes the increase in CBF induced by combined inhibition of adenosine deaminase and adenosine kinase while augmenting ISF adenosine.
